SCHEMBL22639290

SCHEMBL22639290

CCc1cccc(CCC(C)c2ncccc2Cl)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 2/20 0.35
▸ CYP2D6 P10635 1/20 0.34
▸ HRH1 P35367 1/20 0.34
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ GAA P10253 2/20 0.32
▸ SLC6A4 P31645 2/20 0.32
▸ SLC6A2 P23975 1/20 0.32
▸ SLC6A3 Q01959 1/20 0.32
▸ PDE10A Q9Y233 1/20 0.32
▸ HCRTR1 O43613 1/20 0.30
▸ HCRTR2 O43614 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ POLB P06746 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ HTR2A P28223 1/20 0.30
▸ HTR2C P28335 1/20 0.30
▸ HTR2B P41595 1/20 0.30
▸ SYK P43405 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22639190 0.85 CYP2D6 (0.34) KCNH2CYP2D6HRH1NPC1RAB9A
SCHEMBL23982947 0.78 CYP2D6 (0.38) CYP2D6HRH1NPC1RAB9AGAA
SCHEMBL23982943 0.74 CYP2D6 (0.39) CYP2D6HRH1NPC1RAB9ASLC6A4
SCHEMBL12123987 0.72 KCNH2 (0.47) KCNH2NPSR1SYK
SCHEMBL22639191 0.70 RIPK1 (0.38) CYP2D6HRH1SLC6A4SLC6A2SLC6A3
SCHEMBL18993963 0.70 HTR1A (0.33) KCNH2
SCHEMBL2689899 0.70 CYP2D6 (0.39) CYP2D6HRH1SLC6A4SLC6A2SLC6A3
SCHEMBL1690313 0.68 CYP2D6 (0.40) CYP2D6HRH1SLC6A4SLC6A2SLC6A3
SCHEMBL22221911 0.68 L3MBTL1 (0.36) CYP2D6HRH1NPC1RAB9AGAA
SCHEMBL23979816 0.68 MAOA (0.32) NPC1RAB9AALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10829485-B2 ATF6 inhibitors and uses thereof BLACK BELT TX LTD (GB) 2020-11-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10829485-B2 ATF6 inhibitors and uses thereof ATF4, XBP1, ATF1 KCNH2 4854/4885CYP2D6 4325/4885HRH1 4128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback